AI Science Tracker
EN

Department of Clinical Laboratory, Jining First People's Hospital, Jining, Shandong, China

1 discovery from 2023

Discoveries

Identification of Biomarkers Associated with Heart Failure Caused by Idiopathic Dilated Cardiomyopathy Using WGCNA and Machine Learning Algorithms

Source check: Source checked. Not independent scientific confirmation.

Finding: WGCNA, SVM-RFE and LASSO identified 13 candidate genes from idiopathic-dilated-cardiomyopathy heart-failure expression data. AQP3 and CYP2J2 showed diagnostic signal in GEO datasets GSE57338 and GSE6406, respectively; this is retrospective transcriptomic analysis, not clinical validation.

Technology: Weighted gene co-expression network analysis (WGCNA) narrowed candidate genes; SVM-RFE and LASSO selected biomarkers, then external GEO expression datasets checked AQP3 and CYP2J2.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Weighted gene co-expression network analysis (WGCNA) narrowed candidate genes; SVM-RFE and LASSO selected biomarkers, then external GEO expression datasets checked AQP3 and CYP2J2.
Test and result
WGCNA, SVM-RFE and LASSO identified 13 candidate genes from idiopathic-dilated-cardiomyopathy heart-failure expression data
Limitation / still unknown
AQP3 and CYP2J2 showed diagnostic signal in GEO datasets GSE57338 and GSE6406, respectively; this is retrospective transcriptomic analysis, not clinical validation.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC10154102/ · https://pubmed.ncbi.nlm.nih.gov/37143707/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.